Synthesis, activity and mechanism of alkoxy-, carbamato-, sulfonamido-, thioureido-, and ureido-derivatives of 2,4,5-trimethylpyridin-3-ol against inflammatory bowel disease

References

• Dave M, Loftus EV. Jr. Mucosal healing in inflammatory bowel disease-a true paradigm of success? Gastroenterol Hepato 2012;8:29–38.
   PubMedGoogle Scholar
• Theodorou E, Cao P, Karagiannis F, et al. P135 Biological evidence of tofacitinib efficacy in crohn's disease. Gastroenterology 2018;154:S70–S71.
   Web of Science ®Google Scholar
• Xu XR, Liu CQ, Feng BS, Liu ZJ. Dysregulation of mucosal immune response in pathogenesis of inflammatory bowel disease. World J Gastroentero 2014;20:3255–64.
   PubMed Web of Science ®Google Scholar
• Ahluwalia B, Moraes L, Magnusson MK, Öhman L. Immunopathogenesis of inflammatory bowel disease and mechanisms of biological therapies. Scand J Gastroentero 2018;53:379–89.
   PubMed Web of Science ®Google Scholar
• Sanchez-Muñoz F, Dominguez-Lopez A, Yamamoto-Furusho JK. Role of cytokines in inflammatory bowel disease. World J Gastroentero 2008;14:4280–8.
   PubMed Web of Science ®Google Scholar
• Taylor RA, Leonard MC. Curcumin for inflammatory bowel disease: a review of human studies. Altern Med Rev 2011;16:152–6.
   PubMedGoogle Scholar
• Liu SP, Dong WG, Wu DF, et al. Protective effect of angelica sinensis polysaccharide on experimental immunological colon injury in rats. World J Gastroentero 2003;9:2786–90.
   PubMed Web of Science ®Google Scholar
• Fuss IJ, Boirivant M, Lacy B, Strober W. The interrelated roles of TGF-β and IL-10 in the regulation of experimental colitis. J Immunol 2002;168:900–8.
   PubMed Web of Science ®Google Scholar
• Jarry A, Bossard C, Bou-Hanna C, et al. Mucosal IL-10 and TGF-beta play crucial roles in preventing LPS-driven, IFN-gamma-mediated epithelial damage in human colon explants. J Clin Invest 2008;118:1132–42.
   PubMed Web of Science ®Google Scholar
• Couper KN, Blount DG, Riley EM. IL-10: The master regulator of immunity to infection. J Immunol 2008;180:5771–7.
   PubMed Web of Science ®Google Scholar
• Latz E, Xiao TS, Stutz A. Activation and regulation of the inflammasomes. Nat Rev Immunol 2013;13:397–411.
   PubMed Web of Science ®Google Scholar
• Zhen Y, Zhang H. NLRP3 inflammasome and inflammatory bowel disease. Front Immunol 2019;10:276.
   PubMed Web of Science ®Google Scholar
• Perera AP, Fernando R, Shinde T, et al. MCC950, a specific small molecule inhibitor of NLRP3 inflammasome attenuates colonic inflammation in spontaneous colitis mice. Sci Rep 2018;8:8618.
   PubMed Web of Science ®Google Scholar
• Kim DG, Kang Y, Lee H, et al. 6-Amino-2,4,5-trimethylpyridin-3-ols: a new general synthetic route and antiangiogenic activity. Eur J Med Chem 2014;78:126–39.
   PubMed Web of Science ®Google Scholar
• Lee H, Banskota S, Kim DG, et al. Synthesis and antiangiogenic activity of 6-amido-2,4,5-trimethylpyridin-3-ols. Bioorg Med Chem Lett 2014;24:3131–6.
   PubMed Web of Science ®Google Scholar
• Lee H, Kim DG, Banskota S, et al. Pyridoxine-derived bicyclic amido-, ureido-, and carbamato-pyridinols: synthesis and antiangiogenic activities. Org Biomol Chem 2014;12:8702–10.
   PubMed Web of Science ®Google Scholar
• Shah S, Lee C, Choi H, et al. 5-Hydroxy-7-azaindolin-2-one, a novel hybrid of pyridinol and sunitinib: design, synthesis and cytotoxicity against cancer cells. Org Biomol Chem 2016;14:4829–41.
   PubMed Web of Science ®Google Scholar
• Banskota S, Kang HE, Kim DG, et al. In vitro and in vivo inhibitory activity of 6-amino-2,4,5-trimethylpyridin-3-ols against inflammatory bowel disease. Bioorg Med Chem Lett 2016;26:4587–91.
   PubMed Web of Science ®Google Scholar
• Park SW, Banskota S, Gurung P, et al. Synthesis and evaluation of 6-heteroarylamino-2,4,5-trimethylpyridin-3-ols as inhibitors of TNF-α-induced cell adhesion and inflammatory bowel disease. MedChemComm 2018;9:1305–10.
   PubMed Web of Science ®Google Scholar
• Bae D, Gautam J, Jang H, et al. Protective effects of 6-ureido/thioureido-2,4,5-trimethylpyridin-3-ols against 4-hydroxynonenal-induced cell death in adult retinal pigment epithelial-19 cells. Bioorg Med Chem Lett 2018;28:107–12.
   PubMed Web of Science ®Google Scholar
• Thapa D, Lee JS, Park SY, et al. Clotrimazole ameliorates intestinal inflammation and abnormal angiogenesis by inhibiting interleukin-8 expression through a nuclear factor-κB-dependent manner. J Pharmacol Exp Ther 2008;327:353–64.
   PubMed Web of Science ®Google Scholar
• Thapa D, Lee JS, Park MA, et al. Inhibitory effects of clotrimazole on TNF-α-induced adhesion molecule expression and angiogenesis. Arch Pharm Res 2009;32:593–603.
   PubMed Web of Science ®Google Scholar
• Seibel J, Molzberger AF, Hertrampf T, et al. Oral treatment with genistein reduces the expression of molecular and biochemical markers of inflammation in a rat model of chronic TNBS-induced colitis. Eur J Nutr 2009;48:213–20.
   PubMed Web of Science ®Google Scholar
• Wynn TA, Vannella KM. Macrophages in tissue repair, regeneration, and fibrosis. Immunity 2016;44:450–62. 25.
   PubMed Web of Science ®Google Scholar
• Zhang C, Shu W, Zhou G, et al. Anti-TNF-α therapy suppresses proinflammatory activities of mucosal neutrophils in inflammatory bowel disease. Mediat Inflamm 2018;2018:1.
   Web of Science ®Google Scholar
• Weinheimer-Haus EM, Mirza RE, Koh TJ. Nod-like receptor protein-3 inflammasome plays an important role during early stages of wound healing. PloS One 2015;10:e0119106.
   PubMed Web of Science ®Google Scholar
• Luo X, Yu Z, Deng C, et al. Baicalein ameliorates tnbs-induced colitis by suppressing tlr4/myd88 signaling cascade and nlrp3 inflammasome activation in mice. Sci Rep 2017;7:16374.
   PubMed Web of Science ®Google Scholar
• Adegbola SO, Sahnan K, Warusavitarne J, et al. Anti-tnf therapy in crohn's disease. Int J Mol Sci 2018;19:2244.
   PubMed Web of Science ®Google Scholar
• Asquith M, Powrie F. An innately dangerous balancing act: intestinal homeostasis, inflammation, and colitis-associated cancer. J Exp Med 2010;207:1573–7.
   PubMed Web of Science ®Google Scholar
• Tateishi H, Mitsuyama K, Toyonaga A, et al. Role of cytokines in experimental colitis: relation to intestinal permeability. Digestion 1997;58:271–81.
   PubMed Web of Science ®Google Scholar
• Stevens C, Walz G, Singaram C, et al. Tumor necrosis factor-α, interleukin-1β, and interleukin-6 expression in inflammatory bowel disease. Digest Dis Sci 1992;37:818–26.
   PubMed Web of Science ®Google Scholar
• Kucharzik T, Stoll R, Lügering N, Domschke W. Circulating antiinflammatory cytokine IL‐10 in patients with inflammatory bowel disease (IBD). Clin Exp Immunol 2008;100:452–6.
   Google Scholar
• Fiorucci S, Antonelli E, Distrutti E, et al. NCX-1015, a nitric-oxide derivative of prednisolone, enhances regulatory T cells in the lamina propria and protects against 2,4,6-trinitrobenzene sulfonic acid-induced colitis in mice. Proc Natl Acad Sci USA 2002;99:15770–5.
   PubMed Web of Science ®Google Scholar
• de Oliveira GAL, de la Lastra CA, Rosillo MÁ, et al. Preventive effect of bergenin against the development of TNBS-induced acute colitis in rats is associated with inflammatory mediators inhibition and NLRP3/ASC inflammasome signaling pathways. Chem Biol Interact 2019;297:25–33.
   PubMed Web of Science ®Google Scholar
• Kashiwagi I, Morita R, Schichita T, et al. Smad2 and Smad3 inversely regulate TGF-β autoinduction in Clostridium butyricum-activated dendritic cells. Immunity 2015;43:65–79.
   PubMed Web of Science ®Google Scholar
• Torchinsky MB, Garaude J, Martin AP, Blander JM. Innate immune recognition of infected apoptotic cells directs T(H)17 cell differentiation. Nature 2009;458:78–82.
   PubMed Web of Science ®Google Scholar
• Babyatsky MW, Rossiter G, Podolsky DK. Expression of transforming growth factors alpha and beta in colonic mucosa in inflammatory bowel disease. Gastroenterology 1996;110:975–84.
   PubMed Web of Science ®Google Scholar
• McCabe RP, Secrist H, Botney M, et al. Cytokine mRNA expression in intestine from normal and inflammatory bowel disease patients. Clin Immunol Immunop 1993;66:52–8.
   PubMedGoogle Scholar
• Ihara S, Hirata Y, Koike K. TGF-β in inflammatory bowel disease: a key regulator of immune cells, epithelium, and the intestinal microbiota. J Gastroenterol 2017;52:777–87.
   PubMed Web of Science ®Google Scholar
• Strober W, Ludviksson BR, Fuss IJ. The pathogenesis of mucosal inflammation in murine models of inflammatory bowel disease and Crohn disease. Ann Intern Med 1998;128:848–56.
   PubMed Web of Science ®Google Scholar
• Amarante-Mendes GP, Adjemian S, Branco LM, et al. Pattern recognition receptors and the host cell death molecular machinery. Front Immunol 2018;9:2379.
   PubMed Web of Science ®Google Scholar
• Suresh R, Mosser DM. Pattern recognition receptors in innate immunity, host defense, and immunopathology. Adv Physiol Educ 2013;37:284–91.
   PubMed Web of Science ®Google Scholar
• Ranson N, Kunde D, Eri R. Regulation and sensing of inflammasomes and their impact on intestinal health. Int J Mol Sci 2017;18:2379.
   Web of Science ®Google Scholar
• Sutterwala FS, Ogura Y, Szczepanik M, et al. Critical role for NALP3/CIAS1/Cryopyrin in innate and adaptive immunity through its regulation of caspase-1. Immunity 2006;24:317–27.
   PubMed Web of Science ®Google Scholar
• Lamkanfi M, Dixit VM. The inflammasomes. PLoS Pathogens 2009;5:e1000510.
   PubMed Web of Science ®Google Scholar